-
Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at William Blair
Source: Buzz FX / 01 Mar 2025 12:21:13 America/Chicago
Xenon Pharmaceuticals' (XENE) "Outperform" Rating Reaffirmed at William Blair Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Xenon Pharmaceuticals ( NASDAQ:XENE - Get Free Report ) 's stock had its "outperform" rating r
Read more...